| J3111 | Injection, romosozumab-aqqg, 1 mg | 57,230 | $10 | $457.8K |
| J3262 | Injection, tocilizumab, 1 mg | 81,880 | $10 | $409.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 30,000 | $1 | $120K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,850 | $10 | $108.3K |
| J0897 | Injection, denosumab, 1 mg | 4,200 | $20 | $75.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $80 | $54.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 770 | $50 | $38.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $90 | $26.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 130 | $150 | $19.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 190 | $60 | $11K |